Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia

NCT03288441 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Neoplasms
Thrombocytopenia
Anticoagulants
Platelet Aggregation Inhibitors

Interventions

DRUG: Hold
DRUG: Prophylactic dose antithrombotic
DRUG: Change antithrombotic Drug
BIOLOGICAL: Change platelet transfusion threshold
DRUG: Full dose antithrombotics
DEVICE: Mechanical measures
DRUG: Intermediate dose antithrombotic

Sponsor

Maastricht University Medical Center